Bone Biologics (BBLG) Notes Payables (2016 - 2017)
Historic Notes Payables for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $2.9 million.
- Bone Biologics' Notes Payables changed N/A to $2.9 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2016, which is N/A changed from last year.
- Bone Biologics' Notes Payables amounted to $2.9 million in Q3 2017.
- Over the past 5 years, Bone Biologics' Notes Payables peaked at $2.9 million during Q3 2017, and registered a low of $1.2 million during Q4 2016.